Manhattan Associates Inc. filings document operating results, governance and executive compensation for a Georgia-incorporated supply chain and omnichannel commerce software company. Form 8-K reports furnish quarterly earnings releases and discuss GAAP results alongside adjusted operating income, adjusted net income and adjusted diluted earnings per share.
The company’s regulatory record also includes current reports on officer succession and related compensation arrangements, including restricted stock units and executive employment terms. Its definitive proxy materials cover board and shareholder matters, executive pay tables, equity awards and pay-versus-performance disclosures.
Manhattan Associates director Kimberly A. Kuryea received an equity grant as part of her compensation. On May 14, 2026, she acquired 1,940 shares of common stock at no cost through a restricted stock unit award under the company’s stock incentive plan. The units vest fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date. Following this grant, she directly holds 8,027 shares of Manhattan Associates common stock.
Hollembaek Linda T. reported acquisition or exercise transactions in this Form 4 filing.
Manhattan Associates Inc. director Linda T. Hollembaek received a grant of 1,940 shares of common stock as restricted stock units under the company’s stock incentive plan. The award was at no cash cost per share and lifts her direct holdings to 13,847 shares, vesting fully on the earlier of the next annual shareholders’ meeting or the first anniversary of the grant date.
Eger Edmond reported acquisition or exercise transactions in this Form 4 filing.
MANHATTAN ASSOCIATES INC director Edmond Eger reported an equity award of company stock. He received 1,940 shares of common stock as a restricted stock unit grant under the company’s stock incentive plan, reported at a transaction price of $0.00 per share.
The grant vests fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date. Following this award, Eger’s direct ownership stands at 8,453 shares of common stock.
MORAN CHARLES E reported acquisition or exercise transactions in this Form 4 filing.
MANHATTAN ASSOCIATES INC director Charles E. Moran reported an equity award and updated holdings. He received a grant of 1,940 shares of Common Stock at $0.0000 per share as a compensation-related award, lifting his direct holdings to 3,270 shares. The award is a restricted stock unit grant under the company’s stock incentive plan, vesting fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date. Moran also reported 20,808 shares held indirectly by a trust, reflecting his indirect ownership position.
NOONAN THOMAS E reported acquisition or exercise transactions in this Form 4 filing.
MANHATTAN ASSOCIATES INC director Thomas E. Noonan received a grant of 1,940 shares of common stock in the form of restricted stock units under the company’s stock incentive plan. The award vests in full on the earlier of the next annual shareholder meeting or the first anniversary of the grant date.
Following this equity award, Noonan directly holds 103,800 shares of Manhattan Associates common stock, reflecting routine, compensation-related stock-based pay rather than an open-market purchase.
Capel Eddie reported acquisition or exercise transactions in this Form 4 filing.
MANHATTAN ASSOCIATES INC director Eddie Capel received 1,940 shares of Common Stock as a restricted stock unit grant. The award was made at no cash cost per share as part of the company’s stock incentive plan. Following this grant, Capel directly holds 156,329 shares of the company’s common stock.
The restricted stock units vest fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date, aligning director compensation with shareholder interests over that period.
Manhattan Associates, Inc. reported the results of its 2026 Annual Meeting of Shareholders. As of the March 18, 2026 record date, 59,162,073 common shares were entitled to vote, and 55,764,873 shares were present in person or by proxy, representing about 94% participation.
Shareholders elected Class I directors Eddie Capel, Charles E. Moran, and Linda T. Hollembaek to terms expiring in 2029. They also approved, on a non-binding basis, the compensation of the named executive officers, ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved the First Amendment to the company’s 2020 Equity Incentive Plan.
MANHATTAN ASSOCIATES INC: T. Rowe Price Investment Management, Inc. reports beneficial ownership of 3,544,480 shares of Common Stock, equal to 5.9% of the class as of 03/31/2026. The filing lists sole voting power of 3,534,123 shares and includes a statement denying beneficial ownership.
Manhattan Associates Schedule 13G: AQR Capital Management reports beneficial ownership of 3,162,052 shares of Common Stock, representing 5.28% of the class as of 03/31/2026. The filing shows shared voting power of 3,090,463 shares. Filers are AQR Capital Management, LLC and parent AQR Capital Management Holdings, LLC; AQR LLC is a wholly owned subsidiary. The form was signed on 05/14/2026.
Vanguard Capital Management reported beneficial ownership of 3,140,251 shares of Manhattan Associates Inc common stock, representing 5.24% of the class. The filer reports sole voting power for 457,644 shares and sole dispositive power for 3,140,251 shares. The filing is signed by Ashley Grim on 04/30/2026.